Skip to main content

Fatigue severity in low disability MS patients participating in a phase III trial of Avonex(TM) (IFN beta-1a) for relapsing multiple sclerosis

Publication ,  Conference
Cookfair, DL; Fischer, J; Rudick, R; Jacobs, L; Herndon, R; Richert, J; Salazar, A; Granger, C; Simon, J; Goodkin, D
Published in: NEUROLOGY
1997

Duke Scholars

Published In

NEUROLOGY

ISSN

0028-3878

Publication Date

1997

Volume

48

Issue

3

Start / End Page

3066 / 3066

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cookfair, D. L., Fischer, J., Rudick, R., Jacobs, L., Herndon, R., Richert, J., … Goodkin, D. (1997). Fatigue severity in low disability MS patients participating in a phase III trial of Avonex(TM) (IFN beta-1a) for relapsing multiple sclerosis. In NEUROLOGY (Vol. 48, pp. 3066–3066).
Cookfair, D. L., J. Fischer, R. Rudick, L. Jacobs, R. Herndon, J. Richert, A. Salazar, C. Granger, J. Simon, and D. Goodkin. “Fatigue severity in low disability MS patients participating in a phase III trial of Avonex(TM) (IFN beta-1a) for relapsing multiple sclerosis.” In NEUROLOGY, 48:3066–3066, 1997.
Cookfair DL, Fischer J, Rudick R, Jacobs L, Herndon R, Richert J, et al. Fatigue severity in low disability MS patients participating in a phase III trial of Avonex(TM) (IFN beta-1a) for relapsing multiple sclerosis. In: NEUROLOGY. 1997. p. 3066–3066.
Cookfair DL, Fischer J, Rudick R, Jacobs L, Herndon R, Richert J, Salazar A, Granger C, Simon J, Goodkin D. Fatigue severity in low disability MS patients participating in a phase III trial of Avonex(TM) (IFN beta-1a) for relapsing multiple sclerosis. NEUROLOGY. 1997. p. 3066–3066.

Published In

NEUROLOGY

ISSN

0028-3878

Publication Date

1997

Volume

48

Issue

3

Start / End Page

3066 / 3066

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences